Dacomitinib

API0232656

Dacomitinib is an anticancer drug (EGFR inhibitor).

Product Size

Quantity

Pharm Gradet

Standard

Registration

Inquiry

API Description

API Details

Document

Related Patent Status

CAS No.

1110813-31-4
Synonyms

(E)-N-(4-((3-chloro-4-fluorophenyl)aMino)-7-Methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enaMide; 829-313-8
CHEMBL ID

CHEMBL2110732
Indications
Molecule Type

Small molecule
Compound CID

11511120

Molecular Weight (g/mol)

469.9
Molecular Formula

C24H25ClFN5O2
InChI

InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+
InChIKey

LVXJQMNHJWSHET-AATRIKPKSA-N
SMILES

COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)/C=C/CN4CCCCC4
IUPAC Name

(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide
Exact Mass (Da)

469.1680809
Monoisotopic Mass (Da)

469.1680809

OUR PRODUCTS